COMPARISON OF CURRENT AND PREFERRED STATUS OF HTA IMPLEMENTATION IN CENTRAL AND EASTERN EUROPEN COUNTRIES
Author(s)
Kalo Z1, Csanadi M2, Vitezic D3, Huic M4, Husereau D5, Kristensen FB6
1Eötvös Loránd University, Budapest, Hungary, 2Syreon Research Institute, Budapest, Hungary, 3University of Rijeka, School of Medicine and University Hospital Centre Rijeka, Rijeka, Croatia, 4Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, Croatia, 5Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada, 6Danish Health and Medicines Authority, Copenhagen, Denmark
OBJECTIVES: To assess current status of HTA implementation in Central-Eastern European (CEE) countries and to identify long-term objectives considering country specific aspects and regional commonalities. METHODS: An HTA implementation survey was designed to identify, present and discuss HTA roadmaps in CEE countries. The survey was conducted among participants at the Fifth Adriatic Congress of Pharmacoeconomics and Outcomes Research (Sibenik) and at the Pilot ISPOR HTA Training for CEE countries in June 2015 (Zagreb). Opinion of respondents on current and preferred future status of HTA implementation in their own country were described related to capacity building, HTA financing, process and organisational structure for HTA, standardization of HTA methodology, use of local data, scope of mandatory HTA, and decision criteria. RESULTS:
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PHP141
Topic
Economic Evaluation, Health Policy & Regulatory, Health Technology Assessment
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Decision & Deliberative Processes, Reimbursement & Access Policy
Disease
Multiple Diseases